News
SIRO Clinpharm partners with ACROSS Global Alliance; aims to bridge the gap in the pharmaceutical service provider market
SIRO Clinpharm, a Clinical Research Organisation in India announced that they have become a partner of ACROSS Global Alliance (ACROSS) and will help represent India in working towards the common goals and objectives of ACROSS in bridging a gap...
Drug Research
Anixa Biosciences, OntoChem ink pact to proceed to next stage of development of potential anti-viral therapy for Covid-19
Anixa Biosciences, Inc., a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced that based on Proof of Concept (POC) animal study results, it will progress to the next stage of development of its...
News
Crystec launch a new R&D centre in Haimen, Jiangsu province, China
Crystec are pleased to announce the opening of a new subsidiary, Nantong Crystec Pharmaceutical R&D Co. Ltd., and research facility, located at Haimen Science and Technology Park in Haimen City, Jiangsu Province, China.
Crystec’s new R&D centre has been established...
Drug Research
Iconovo and ISR develop new covid-19 inhalation vaccine
Inhalation device company Iconovo, which offers complete inhalation products, signed an agreement with immunotherapy company ISR Immune System Regulation. The agreement concerns the development of an inhalation vaccine against Covid-19 in Iconovo’s disposable inhaler ICOone. The parties see significant...
News
Moderna Provides Storage Update & Announces the U.S. FDA Authorizes Up To 15-Doses Per Vial of its COVID-19 Vaccine
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that based on submitted stability data, the U.S. FDA has authorized the Moderna COVID-19 Vaccine to be kept at room temperature conditions once removed from the...
News
Auxita and MyMeds&Me Announce Strategic Partnership to Deliver Integrated Digital Pharmacovigilance Capabilities
Healthcare providers across Canada will soon be able to capture adverse events in the Auxita platform through integration with MyMeds&Me’s pharmacovigilance SaaS platform, Reportum®.
Auxita solves the administrative burden for providers by digitizing workflows and providing interoperability with patient support...
Clinical Trials
OSE Immunotherapeutics Receives Authorization for Phase 1 Clinical Trial of its Multi-Target Multi-Variant COVID-19 Vaccine
OSE Immunotherapeutics announced that the Belgian Federal Agency for Medicines and Health Products (Agence Fédérale des Médicaments et des Produits de Santé - AFMPS) and the Belgian Ethics Committee approved the Phase 1 trial evaluating its COVID-19 vaccine, named...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read